Dr Stoten will be taking over from retiring Managing Director Linda Naylor from April.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Oxford Cancer Biomarker’s ColoTox test will now be available to UK patients considering chemotherapy.
Oxford University and Evotec’s drug discovery partnership launched last year to quickly accelerate drugs to market begins making awards.
Following research showing Oxford University has produced more founders of billion-dollar startups than any other institution in Europe, Oxford University Innovation’s Gregg Bayes-Brown takes a closer look at the founders, their ties to Oxford, and the companies they’ve launched.
Oxford University Innovation’s management consultancy division to restructure as separate entity to scale up interactions and business on the world stage.
The collaboration will see Drayson Technologies bring to market Oxford technologies that can positively impact on patient health outcomes, admissions, and costs within the NHS.
Oxford spinout Celleron Therapeutics raises funding from South Korean consortium of investors for small molecule treatments.
Isis Enterprise, the global consultancy arm of Oxford University, is due to hold its next technology transfer training course on the 1st and 2nd of February 2017.